<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02166333</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00063914</org_study_id>
    <secondary_id>U01AG047837</secondary_id>
    <nct_id>NCT02166333</nct_id>
  </id_info>
  <brief_title>Study To Understand Fall Reduction and Vitamin D in You</brief_title>
  <acronym>STURDY</acronym>
  <official_title>Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D supplements might substantially reduce the risk of falls, potentially by more than&#xD;
      25%. The proposed study is a clinical trial that will determine the effects of 4 doses of&#xD;
      vitamin D (200 International Units [IU]/day, 1000 IU/day, 2000 IU/d and 4000 IU/d) as a means&#xD;
      to prevent falls in high-risk adults, ages 70 and older. Results of this trial will be&#xD;
      directly relevant to public health and clinical guidelines, and will immediately influence&#xD;
      policy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The public health burden of falls in older persons is substantial. Several lines of evidence&#xD;
      suggest that vitamin D supplements might reduce the risk of falls, potentially by 25% or more&#xD;
      in persons with low serum 25-hydroxyvitamin D [25(OH)D] levels. However, existing evidence is&#xD;
      inconsistent and insufficient to guide policy. The trial is a seamless two-stage, Bayesian&#xD;
      response-adaptive, randomized dose-finding trial designed to select the best dose of vitamin&#xD;
      D supplementation and to potentially confirm the efficacy of that dose for fall prevention&#xD;
      and other related outcomes. Participants will be community-dwelling adults, aged 70+ (goal of&#xD;
      ~40% black, ~60% women), with a baseline serum 25(OH)D level of 10-29 ng/ml, who are at high&#xD;
      risk for falling.&#xD;
&#xD;
      In Stage 1 of the adaptive design, participants will be randomly assigned to one of four&#xD;
      vitamin D3 (cholecalciferol) doses: 200 IU/d (control), 1000 IU/d, 2000 IU/d, or 4000 IU/d,&#xD;
      with assignment probabilities that will vary as falls are reported. Participants will take&#xD;
      their assigned pills for two years, or until the study ends, whichever comes first. This&#xD;
      stage of the design will select the best non control dose of vitamin D for prevention of&#xD;
      falls, or confirm the futility of distinguishing any differences among the non control doses&#xD;
      for fall prevention. If a best dose is selected, subsequent participants will be randomized&#xD;
      in Stage 2 of the trial into the comparison (200 IU/d) or best dose group, and all&#xD;
      participants (Stage 1 and Stage 2) will continue to be followed to potentially confirm&#xD;
      efficacy. The investigators anticipate enrolling approximately 1,200 participants over the&#xD;
      entire length of the project.&#xD;
&#xD;
      The primary outcome is time to first fall (or death) over two years of therapy. Next in&#xD;
      importance is the outcome of gait speed. Other outcomes include fall rates, types of falls,&#xD;
      balance, muscle strength, frailty, Short Physical Performance Battery (SPPB) score, 6-minute&#xD;
      walk time, and physical activity assessed by accelerometry. Falls will be ascertained from&#xD;
      fall calendars completed daily by participants and from self-report by phone. In-person&#xD;
      follow-up visits will occur at 3, 12, and 24 months, with telephone visits occurring at 1, 6,&#xD;
      9, 15, 18, and 21 months after randomization. Subgroups with potential for greater benefit&#xD;
      from vitamin D supplementation are blacks, those with baseline 25(OH)D of 10-19 ng/ml, and&#xD;
      those with objective evidence of low physical function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">June 30, 2015</start_date>
  <completion_date type="Actual">June 7, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of First Fall or Death (Whichever Comes First)</measure>
    <time_frame>Randomization to 24 months or end of trial, whichever came first</time_frame>
    <description>Falls were ascertained by a monthly fall calendar completed by each participant, scheduled interviews at 1 month and 3 months after randomization and every 3 months thereafter up to 24 months or trial end. Death was ascertained primarily by reports from family or friends.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Gait Speed</measure>
    <time_frame>Baseline, 3 months, 12 months and 24 months</time_frame>
    <description>Gait speed in meters per second (m/s) was obtained from the timed 4-meter, usual-paced walk component of the Short Physical Performance Battery. The change in gait speed was obtained as follow-up measure minus baseline measure.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">688</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Falls</condition>
  <arm_group>
    <arm_group_label>200 IU/d</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1000 IU/d</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2000 IU/d</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4000 IU/d</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>200 IU/d cholecalciferol</intervention_name>
    <arm_group_label>200 IU/d</arm_group_label>
    <other_name>vitamin D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>1000 IU/d cholecalciferol</intervention_name>
    <arm_group_label>1000 IU/d</arm_group_label>
    <other_name>vitamin D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2000 IU/d cholecalciferol</intervention_name>
    <arm_group_label>2000 IU/d</arm_group_label>
    <other_name>vitamin D3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>4000 IU/d cholecalciferol</intervention_name>
    <arm_group_label>4000 IU/d</arm_group_label>
    <other_name>vitamin D3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 70 and older&#xD;
&#xD;
          -  Non-institutionalized&#xD;
&#xD;
          -  High risk for falling, defined by a 'yes' response to at least one of the following:&#xD;
&#xD;
          -  1. Have you fallen and hurt yourself in the past year?&#xD;
&#xD;
          -  2. Have you fallen 2 or more times in the past year?&#xD;
&#xD;
          -  3. Are you afraid that you might fall because of balance or walking problems?&#xD;
&#xD;
          -  4. Do you have difficulty maintaining your balance when bathing, dressing, or getting&#xD;
             in and out of a chair?&#xD;
&#xD;
          -  5. Do you use a cane, walker, or other device when walking inside or outside your&#xD;
             home?&#xD;
&#xD;
          -  Serum vitamin D [25(OH)D] level of 10-29 ng/ml&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  Willing to accept randomization to each vitamin D dose&#xD;
&#xD;
          -  One of the following:&#xD;
&#xD;
          -  1. No vitamin D supplementation at baseline&#xD;
&#xD;
          -  2. Average daily vitamin D supplementation judged by study staff as being consistent&#xD;
             with the goal of 1000 IU/day or less at screening and willing to continue the dose&#xD;
             unchanged throughout the trial&#xD;
&#xD;
          -  One of the following:&#xD;
&#xD;
          -  1. No calcium supplementation at baseline&#xD;
&#xD;
          -  2. Average daily calcium supplementation judged by study staff as being consistent&#xD;
             with the goal of 1200 mg/day or less at screening and willing to continue the dose&#xD;
             unchanged throughout the trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment, defined by Mini-Mental State Exam (MMSE) score &lt;24&#xD;
&#xD;
          -  Hypercalcemia, serum Ca++ 11.0 mg/dl or higher or &gt;10.5 mg/dl (confirmed)&#xD;
&#xD;
          -  Hypocalcemia, serum Ca++ &lt;8.5 mg/dl&#xD;
&#xD;
          -  Kidney, ureteral, or bladder stones made of calcium compounds (2 or more in lifetime,&#xD;
             or 1 in the last 2 years); in the absence of information on the type of stone, stones&#xD;
             will be assumed to be made of calcium compounds&#xD;
&#xD;
          -  Planning to move out of area within 2 years, where plans would prevent compliance with&#xD;
             the study protocol&#xD;
&#xD;
          -  Disease or condition expected to cause death or to prevent compliance with the study&#xD;
             protocol in the next 2 years&#xD;
&#xD;
          -  Participation in another trial of vitamin D or falls, or any trial that might affect&#xD;
             the risk of falls&#xD;
&#xD;
          -  Lactose allergy (lactose intolerance is okay)&#xD;
&#xD;
          -  Use of any form of oral or injected calcitriol (brand names: Rocaltrol (R), Calcijex&#xD;
             (R), and Zemplar (R); generic names: calcitriol, paricalcitol, doxycalcitriol,&#xD;
             22-oxacalcitriol)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence J Appel, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ProHealth Clinical Research Unit</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comstock Center for Public Health Research and Prevention</name>
      <address>
        <city>Hagerstown</city>
        <state>Maryland</state>
        <zip>21740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sturdytrial.org</url>
    <description>STURDY study website</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 16, 2014</study_first_submitted>
  <study_first_submitted_qc>June 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2014</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>April 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 14, 2021</results_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>falls</keyword>
  <keyword>high risk of falling</keyword>
  <keyword>insufficient or deficient serum vitamin D levels</keyword>
  <keyword>10-29 ng/ml</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified participant data and data dictionary will be available at https://archive.data.jhu.edu/ starting one year after publication of the primary outcome results, contingent upon Institutional Review Board (IRB) approval.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>One year after publication of primary outcome results. Data are expected to be available in December 2021. Data are expected to remain available in perpetuity.</ipd_time_frame>
    <ipd_access_criteria>Data will be available at https://archive.data.jhu.edu/ contingent on IRB approval of their use.</ipd_access_criteria>
    <ipd_url>https://archive.data.jhu.edu/</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT02166333/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT02166333/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From October 2015 to March 2018, new participants were randomized in the trial's Stage 1 and began their individual 2-year period of trial participation. Stage 1 ended on March 23, 2018 and Stage 2 began; randomization continued but to the 200 and 1000 groups only. Some participants completed their 2 years of participation during Stage 1, some participants had follow-up time during both Stage 1 and Stage 2, and some participants began their 2 years of participation during Stage 2.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Randomized to 200 IU/d in Stage 1</title>
          <description>These participants received 200 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually throughout their trial participation; those who continued to Stage 2 (neither completed the trial [completed the 2-year visit], nor died, nor dropped out during Stage 1) continued to receive 200 IU/d cholecalciferol during Stage 2.</description>
        </group>
        <group group_id="P2">
          <title>Additional Participants Randomized to 200 IU/d in Stage 2</title>
          <description>These participants began their study participation in Stage 2 and received 200 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually throughout their participation.</description>
        </group>
        <group group_id="P3">
          <title>Randomized to 1000 IU/d in Stage 1</title>
          <description>These participants received 1000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually throughout their trial participation; those who continued to Stage 2 (neither completed the trial [completed the 2-year visit], nor died, nor dropped out during Stage 1) continued to receive 1000 IU/d cholecalciferol during Stage 2.</description>
        </group>
        <group group_id="P4">
          <title>Additional Participants Randomized to 1000 IU/d in Stage 2</title>
          <description>These participants began their study participation in Stage 2 and received 1000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually throughout their participation.</description>
        </group>
        <group group_id="P5">
          <title>Randomized to 2000 IU/d in Stage 1 and Switched to 1000 IU/d in Stage 2</title>
          <description>These participants received 2000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually in Stage 1; those who continued to Stage 2 were switched to 1000 IU/d cholecalciferol (vitamin D3) tablets during Stage 2.</description>
        </group>
        <group group_id="P6">
          <title>Randomized to 4000 IU/d in Stage 1 and Switched to 1000 IU/d in Stage 2</title>
          <description>These participants received 4000 IU/d cholecalciferol (vitamin D3) tablets that can be swallowed or consumed sublingually in Stage 1; those who continued to Stage 2 were switched to 1000 IU/d cholecalciferol (vitamin D3) tablets during Stage 2.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Stage 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="262"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="130"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="68">Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding</participants>
                <participants group_id="P6" count="69">Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="242"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="122"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="9"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Stage 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="242"/>
                <participants group_id="P2" count="77"/>
                <participants group_id="P3" count="122"/>
                <participants group_id="P4" count="82"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="71"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="73"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="207"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="75"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="57"/>
                <participants group_id="P6" count="59"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Finished the trial (did the 2 year visit) prior to or during trial closeout</title>
              <participants_list>
                <participants group_id="P1" count="180"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="63"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="54"/>
                <participants group_id="P6" count="52"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>200 IU/d</title>
          <description>The 200 IU/d group is the control group.</description>
        </group>
        <group group_id="B2">
          <title>1000 IU/d</title>
          <description>During dose-finding, the 1000 IU/d dose was identified as the best of the non-control doses for fall prevention.</description>
        </group>
        <group group_id="B3">
          <title>2000 IU/d</title>
          <description>Randomization to the 2000 IU/d group was stopped in February 2018 as part of planned dose-finding.</description>
        </group>
        <group group_id="B4">
          <title>4000 IU/d</title>
          <description>Randomization to the 4000 IU/d group was stopped in March 2018 as part of planned dose-finding.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="339"/>
            <count group_id="B2" value="212"/>
            <count group_id="B3" value="68"/>
            <count group_id="B4" value="69"/>
            <count group_id="B5" value="688"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.2" spread="5.4"/>
                    <measurement group_id="B2" value="76.5" spread="5.3"/>
                    <measurement group_id="B3" value="77.3" spread="4.6"/>
                    <measurement group_id="B4" value="79.1" spread="5.9"/>
                    <measurement group_id="B5" value="77.2" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="28"/>
                    <measurement group_id="B5" value="300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="198"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="41"/>
                    <measurement group_id="B5" value="388"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>7 participants were missing race information, 4 participants were missing ethnicity information</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="335"/>
                    <count group_id="B2" value="210"/>
                    <count group_id="B3" value="67"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="681"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="276"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="57"/>
                    <measurement group_id="B5" value="543"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="335"/>
                    <count group_id="B2" value="210"/>
                    <count group_id="B3" value="67"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="681"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="335"/>
                    <count group_id="B2" value="210"/>
                    <count group_id="B3" value="67"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="681"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic, Latino or Spanish ethnicity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="336"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="684"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="339"/>
                    <measurement group_id="B2" value="212"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="69"/>
                    <measurement group_id="B5" value="688"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum vitamin D (nmol/L)</title>
          <description>The range of serum vitamin D levels eligible for the trial (25-72.5 nmol/L) includes those termed deficient (&lt;50 nmol/L) or insufficient (50-72.5 nmol/L) by the Endocrine Society and overlaps with those termed deficient (&lt;30 nmol/L), inadequate (30 to &lt;50 nmol/L), or adequate (â‰¥50 nmol/L) by the Institute of Medicine.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>25 to 49 nmol/L</title>
                  <measurement_list>
                    <measurement group_id="B1" value="100"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="22"/>
                    <measurement group_id="B5" value="200"/>
                  </measurement_list>
                </category>
                <category>
                  <title>50 to 72.5 nmol/L</title>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Taking a vitamin D supplement</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="256"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total vitamin D intake (IU/day)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt; 200</title>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="253"/>
                  </measurement_list>
                </category>
                <category>
                  <title>200-399</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="138"/>
                  </measurement_list>
                </category>
                <category>
                  <title>400-799</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;= 800</title>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fell at least once in prior year</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="221"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fell and hurt self in prior year</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="262"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fell at least twice in prior year</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="83"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="259"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Afraid of falling due to balance or walking problem</title>
          <population>1 participant in the 1000 IU/day group did not answer the question regarding fear of falling due to balance or walking problem.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="687"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="290"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="65"/>
                    <measurement group_id="B4" value="56"/>
                    <measurement group_id="B5" value="601"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Difficulty maintaining balance</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="343"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Uses cane, walker or other assistive device to walk</title>
          <population>1 participant in the 1000 IU/day group did not answer the question about using an assistive device to walk.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="687"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Short Physical Performance Battery score</title>
          <description>The Short Physical Performance Battery (SPPB) is a 3-part assessment of physical functioning: balance testing, gait speed testing (timed 4-meter walk at usual pace), and demonstration of ability to complete 5 chair stands; each part is scored 0 to 4 and the 3 subscores are summed to obtain the total score which ranges from 0 to 12. Higher scores indicate better physical function.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="212"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="688"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 to 3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4 to 6</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>7 to 9</title>
                  <measurement_list>
                    <measurement group_id="B1" value="131"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="24"/>
                    <measurement group_id="B5" value="277"/>
                  </measurement_list>
                </category>
                <category>
                  <title>10 to 12</title>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="31"/>
                    <measurement group_id="B5" value="306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gait speed (m/sec)</title>
          <population>1 participant in the 200 IU/day group and 2 participants in the 1000 IU/day group were missing gait speed at baseline</population>
          <units>meters per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="338"/>
                    <count group_id="B2" value="210"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="685"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.89" spread="0.23"/>
                    <measurement group_id="B2" value="0.85" spread="0.23"/>
                    <measurement group_id="B3" value="0.80" spread="0.23"/>
                    <measurement group_id="B4" value="0.85" spread="0.23"/>
                    <measurement group_id="B5" value="0.86" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Frailty status</title>
          <population>One participant in the 1000 IU/day group was missing frailty status at baseline.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="687"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Robust</title>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Pre-frail</title>
                  <measurement_list>
                    <measurement group_id="B1" value="205"/>
                    <measurement group_id="B2" value="127"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="408"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Frail</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <population>1 participant in the 1000 IU/day group was missing BMI at baseline.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="339"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="687"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.4" spread="6.3"/>
                    <measurement group_id="B2" value="30.7" spread="5.2"/>
                    <measurement group_id="B3" value="30.7" spread="6.4"/>
                    <measurement group_id="B4" value="30.3" spread="6.2"/>
                    <measurement group_id="B5" value="30.5" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SF-12 physical health component score</title>
          <description>The Short-Form 12-Item Health Survey (4-week recall) v2 (SF-12) is an interviewer-administered 12-item scale measuring a person's perceptions of their health and health-related quality of life; the physical component score is based on responses to 6 items and has a normative mean (SD) of 50 (10) (range 0 to 100). Higher scores indicate better physical health.</description>
          <population>4 participants in the 200 IU/day group and 1 participant in the 1000 IU/day group were missing the SF-12 physical component score at baseline.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="335"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="683"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.5" spread="10.3"/>
                    <measurement group_id="B2" value="42.9" spread="11.0"/>
                    <measurement group_id="B3" value="42.9" spread="10.2"/>
                    <measurement group_id="B4" value="44.0" spread="9.9"/>
                    <measurement group_id="B5" value="43.8" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SF-12 mental health component score</title>
          <description>The Short-Form 12-Item Health Survey (4-week recall) v2 (SF-12) is an interviewer-administered 12-item scale measuring a person's perceptions of their health and health-related quality of life; the mental component score is based on responses to 6 items and has a normative mean (SD) of 50 (10) (range 0 to 100). Higher scores indicate better mental health.</description>
          <population>4 participants in the 200 IU/day group and 1 participant in the 1000 IU/day group were missing the SF-12 mental component score at baseline.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="335"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="68"/>
                    <count group_id="B4" value="69"/>
                    <count group_id="B5" value="683"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.1" spread="7.7"/>
                    <measurement group_id="B2" value="55.4" spread="7.6"/>
                    <measurement group_id="B3" value="54.5" spread="8.4"/>
                    <measurement group_id="B4" value="54.3" spread="9.4"/>
                    <measurement group_id="B5" value="55.0" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of First Fall or Death (Whichever Comes First)</title>
        <description>Falls were ascertained by a monthly fall calendar completed by each participant, scheduled interviews at 1 month and 3 months after randomization and every 3 months thereafter up to 24 months or trial end. Death was ascertained primarily by reports from family or friends.</description>
        <time_frame>Randomization to 24 months or end of trial, whichever came first</time_frame>
        <population>The primary efficacy analysis compares the Experience on Best Dose group versus the 200 IU/d group. The Experience on Best Dose group includes all participants assigned or switched to best dose, with their data limited to data while on best dose. This group excludes 41 participants randomized to 2000 or 4000 IU/d who were never issued a bottle of 1000 IU/d because they completed the trial, died, dropped out, or stopped using study pills without ever being switched to 1000 IU/d.</population>
        <group_list>
          <group group_id="O1">
            <title>Experience on Best Dose</title>
            <description>The Experience on Best Dose group includes 121 participants randomized to 1000 IU/d during dose-finding and 96 participants randomized to 2000 or 4000 IU/d during dose-finding who were issued at least one bottle of 1000 IU after dose-finding ended, plus 91 participants randomized to 1000 IU/d after dose-finding ended, for a total of 308 participants who had experience on the dose selected as best of the non-control doses for preventing falls. This group excludes 41 participants randomized to 2000 or 4000 IU/d who were never issued a bottle of 1000 IU/d because they completed the trial, died, dropped out, or stopped using study pills without ever being switched to 1000 IU/d.</description>
          </group>
          <group group_id="O2">
            <title>200 IU/d</title>
            <description>The 200 IU/d group is the control group and includes participants randomized to 200 IU/d during Stage 1 and participants randomized to 200 IU/d during Stage 2.</description>
          </group>
          <group group_id="O3">
            <title>Pooled Higher Doses</title>
            <description>All participants randomized to 1000, 2000, or 4000 IU/d during Stage 1 and all participants randomized to 1000 IU/d during Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of First Fall or Death (Whichever Comes First)</title>
          <description>Falls were ascertained by a monthly fall calendar completed by each participant, scheduled interviews at 1 month and 3 months after randomization and every 3 months thereafter up to 24 months or trial end. Death was ascertained primarily by reports from family or friends.</description>
          <population>The primary efficacy analysis compares the Experience on Best Dose group versus the 200 IU/d group. The Experience on Best Dose group includes all participants assigned or switched to best dose, with their data limited to data while on best dose. This group excludes 41 participants randomized to 2000 or 4000 IU/d who were never issued a bottle of 1000 IU/d because they completed the trial, died, dropped out, or stopped using study pills without ever being switched to 1000 IU/d.</population>
          <units>First fall or death per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="308"/>
                <count group_id="O2" value="339"/>
                <count group_id="O3" value="349"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.9" lower_limit="65.8" upper_limit="89.9"/>
                    <measurement group_id="O2" value="76.0" lower_limit="66.5" upper_limit="86.9"/>
                    <measurement group_id="O3" value="78.0" lower_limit="68.3" upper_limit="89.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The Experience on Best Dose group includes all participants assigned or switched to best dose (1000 IU/day) and excludes 41 participants randomized to 2000 or 4000 IU/day who were never issued a bottle of best dose. For those randomized to 2000 or 4000 IU/day, at-risk time and events are measured from the date of their switch to best dose. 150 Experience on Best Dose participants (median follow-up, 10.2 mos) and 125 200 IU/day participants (median follow-up, 20.3 mos) were censored.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.54</p_value>
            <p_value_desc>The P value is nominal and two-sided.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.76</ci_lower_limit>
            <ci_upper_limit>1.15</ci_upper_limit>
            <estimate_desc>The Experience on Best Dose versus 200 IU/day hazard ratio and its 95% confidence interval were derived from a Cox regression model with dose group as the single model variable.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.25</ci_upper_limit>
            <estimate_desc>The comparison of the Pooled Higher Doses group versus the 200 IU/d group is a sensitivity analysis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Gait Speed</title>
        <description>Gait speed in meters per second (m/s) was obtained from the timed 4-meter, usual-paced walk component of the Short Physical Performance Battery. The change in gait speed was obtained as follow-up measure minus baseline measure.</description>
        <time_frame>Baseline, 3 months, 12 months and 24 months</time_frame>
        <population>Change in gait speed since randomization was evaluated in the Pooled Higher Doses group versus the 200 IU/d group.</population>
        <group_list>
          <group group_id="O1">
            <title>Pooled Higher Doses</title>
            <description>The Pooled Higher Doses group includes all participants randomized to 1000, 2000, or 4000 IU/d (n=349).</description>
          </group>
          <group group_id="O2">
            <title>200 IU/Day</title>
            <description>The 200 IU/d group is the control group.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gait Speed</title>
          <description>Gait speed in meters per second (m/s) was obtained from the timed 4-meter, usual-paced walk component of the Short Physical Performance Battery. The change in gait speed was obtained as follow-up measure minus baseline measure.</description>
          <population>Change in gait speed since randomization was evaluated in the Pooled Higher Doses group versus the 200 IU/d group.</population>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="349"/>
                <count group_id="O2" value="339"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.17"/>
                    <measurement group_id="O2" value="-0.01" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.17"/>
                    <measurement group_id="O2" value="-0.04" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.16"/>
                    <measurement group_id="O2" value="-0.09" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The two groups were assessed for differential change over time in change from baseline using a longitudinal mixed effects regression model with gait speed as the outcome and fixed effects including a single treatment term, 3 time point terms and 3 treatment-by-time interaction terms and a random intercept for participant.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>The overall P tests for difference between groups in differential change from baseline over time and is from a 3 degree of freedom test of the combined 3 treatment-by-time interaction terms from the longitudinal mixed effects model.</non_inferiority_desc>
            <p_value>0.15</p_value>
            <p_value_desc>The P value is nominal and not adjusted for multiple comparisons.</p_value_desc>
            <method>Regression, Linear</method>
            <method_desc>3 degree of freedom interaction test</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event information was collected from randomization to last date of participation in the trial, up to 24 months.</time_frame>
      <desc>Adverse events are reported for the Pooled Higher Doses group (those randomized to 1000, 2000, or 4000 IU) vs. the control group (those randomized to 200 IU) to be consistent with how the study outcomes are reported, because the Pooled Higher Doses and control groups have comparable numbers and follow-up, and because the 2000 and 4000 IU groups received 1000 IU after 1000 IU was selected as best non control dose. Also shown are counts of adverse event by dose in use when the event occurred.</desc>
      <group_list>
        <group group_id="E1">
          <title>Pooled Higher Doses</title>
          <description>The Pooled Higher Doses group includes all participants randomized to 1000, 2000, or 4000 IU/d.</description>
        </group>
        <group group_id="E2">
          <title>200 IU/d</title>
          <description>The 200 IU/d group is the control group.</description>
        </group>
        <group group_id="E3">
          <title>Those With Experience on 1000 IU</title>
          <description>This group includes those randomized to 1000 IU and 96 participants randomized to 2000 or 4000 who were issued at least 1 bottle of 1000 IU. Note that participants who switched doses during the trial may have an event while in their original group as well as in the 1000 group if the event recurred after switching to 1000 IU.</description>
        </group>
        <group group_id="E4">
          <title>Those With Experience on 2000 IU</title>
          <description>Only those randomized to 2000 IU are in this group.</description>
        </group>
        <group group_id="E5">
          <title>Those With Experience on 4000 IU</title>
          <description>Only those randomized to 4000 IU are in this group.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (18.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="82" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="49" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="17" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Gastrointestinal polyp hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Rectal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Fecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Unevaluable event</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Localized infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood calcium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Blood calcium increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Full blood count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Squamous carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>b-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Leukemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cerebral hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Prostatic calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Dypsnea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pulmonary embolus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Internal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (18.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="311" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="299" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="250" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="60" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="63" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="65" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Influenza</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="212" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="207" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="153" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="44" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="47" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="95" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="85" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="54" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="349"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="339"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="308"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="68"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lawrence Appel</name_or_title>
      <organization>Johns Hopkins University</organization>
      <phone>410-955-4156</phone>
      <email>lappel@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

